Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Bacterin International, Inc.
WARNING LETTER
•Bacterin International, Inc.•July 27, 2012

Bacterin International, Inc. – FDA Warning Letter, Jul 27, 2012

Record Details

On July 19-27, 2012, an FDA inspection of Bacterin International, Inc. in Belgrade, Montana, revealed that their Elutia and Via Wound Drains were adulterated and misbranded. The devices were adulterated under Section 501(h) of the Act, 21 U.S.C. § 351(h), due to non-conformity with Current Good Manufacturing Practice (CGMP) requirements of the Quality System (QS) regulation (21 CFR Part 820).

Key violations include: 1. **Failure to establish and maintain procedures for purchased product and services (21 CFR 820.50):** Supplier performance reviews and audits were not conducted as per procedure, exemplified by a significant delay in auditing a supplier despite noted quality issues. The firm's planned updates to the Supplier Qualification system and procedure, and associated retraining, were not provided to the FDA by the stated deadline. 2. **Failure to control nonconforming product (21 CFR 820.90(a)):** A "Use As Is" disposition for a nonconforming lot of Elutia 19 Fr Wound Drain lacked required scientific justification. The firm's planned retraining on Nonconformance Reports and justification, and a letter to file for the specific case, were not documented as completed. 3. **Failure to establish and maintain procedures

Company
Bacterin International, Inc.
Inspection date
July 27, 2012
Product type
Devices
Office
Seattle District Office
Person
  • Charles M. Breen (District Director)
View Company Profile

ID · 62c66682-39ed-4ca3-b0d3-4a3fd4ffeaaf

Violation Codes10
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 82021 CFR 820.5021 CFR 820.90(a)21 CFR 820.80(d)21 CFR 820.4021 U.S.C. 352(t)(2)21 U.S.C. 360i21 CFR 803

Full citation text and observation details available on the Dashboard.

Other documents for Bacterin International, Inc.
  • WARNING_LETTER - 2012-07-26July 26, 2012

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Bacterin International, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.